SFRS8 Activators are an array of chemical compounds that indirectly boost the functional activity of SFRS8, a protein known to be integral in RNA splicing. Compounds like Resveratrol and Trichostatin A facilitate the deacSFRS8 Activators are a diverse group of chemical compounds that indirectly enhance the functional activity of SFRS8, a protein implicated in the regulation of RNA splicing. Resveratrol, through its action on sirtuin 1 (SIRT1), indirectly influences the activity of SFRS8 by modulating protein-protein interactions and splicing regulation. Similarly, Trichostatin A, an inhibitor of histone deacetylase, and Sodium Butyrate create a chromatin context that promotes the transcription of genes involved in splicing, potentially leading to an upsurge in SFRS8 activity. This is mirrored by MS-275 and Vorinostat, which by inhibiting HDAC, could upregulate splicing regulatory proteins, thereby enhancing SFRS8's role. Retinoic Acid and Vitamin D3 function through nuclear receptor pathways to possibly upregulate genes that would increase the functional activity of SFRS8 in RNA processing.
Further contributing to the activation of SFRS8 are epigenetic modifiers like 5-Azacytidine and RG108, which alter DNA methylation patterns, potentially leading to an increased expression of genes that govern splicing, and thus indirectly augmenting SFRS8's activity. S-Adenosylmethionine, by serving as a methyl donor, may also play a role in the expression of splicing-related genes. Additionally, the polyphenol Epigallocatechin Gallate and the natural compound Curcumin are known to affect gene expression; they may modify the expression of genes involved in splicing or alter the phosphorylation state of splicing factors, thereby enhancing SFRS8's function in the spliceosome complex. Collectively, these activators exert their effects through various biochemical pathways, converging on the enhancement of SFRS8's role in the critical cellular process of RNA splicing.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A interacts with estrogen receptors, which can indirectly enhance the activity of SFRS8 by promoting the expression of genes regulated by estrogen, including those involved in RNA splicing where SFRS8 functions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate serine/arginine-rich splicing factors, potentially increasing the functional activity of SFRS8 in spliceosome assembly and alternative splicing regulation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium/calmodulin-dependent protein kinase (CaMK), possibly enhancing the phosphorylation and activity of SFRS8 in splicing. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, activating PKA, which may indirectly enhance the phosphorylation state and activity of SFRS8 in RNA splicing. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA, potentially enhancing SFRS8 activity by phosphorylation and promoting its role in spliceosome assembly and function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which can increase the transcription of genes involved in splicing, potentially upregulating the functional activity of SFRS8 without directly affecting its translation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, another histone deacetylase inhibitor, may enhance the expression of splicing factors by promoting a more relaxed chromatin structure and potentially increasing SFRS8 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several kinases, potentially altering phosphorylation patterns and enhancing the activity of splicing factors such as SFRS8 through indirect modulation of splicing pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate multiple signaling pathways, potentially affecting phosphorylation states and enhancing the activity of SFRS8 in RNA processing and splicing events. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, potentially affecting the activity of calcium-dependent kinases and phosphatases, which may enhance the phosphorylation and functional activity of SFRS8. | ||||||